Denali Therapeutics Inc. (DNLI) SEC Filings — 2025
14 SEC filings for Denali Therapeutics Inc. (DNLI) in 2025.
Filings
- Denali Therapeutics Enters Material Definitive Agreement — 8-K · Dec 10, 2025
- Denali Therapeutics Inc. 8-K Filing — 8-K · Dec 4, 2025
- Denali's Q3 Loss Widens to $126.9M Amid Rising R&D Costs — 10-Q · Nov 6, 2025
- Denali Therapeutics Files 8-K — 8-K · Oct 14, 2025
- Denali's Q2 Revenue Drops 32.5%, Net Loss Widens to $120.1M — 10-Q · Aug 11, 2025
- Denali Therapeutics Files 8-K — 8-K · Jul 7, 2025
- Denali Therapeutics Files 8-K — 8-K · Jun 3, 2025
- Denali Therapeutics Files 8-K on Financials — 8-K · May 6, 2025
- Denali Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 17, 2025
- Denali Therapeutics Files 8-K — 8-K · Apr 2, 2025
- Denali Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Mar 5, 2025
- Denali Therapeutics Inc. 10-K Filing — 10-K · Feb 27, 2025
- Denali Therapeutics Files 8-K — 8-K · Jan 13, 2025
- Denali Therapeutics Files 8-K — 8-K · Jan 7, 2025